drugset / Trial / NCT00428077
Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a peptide may help the body build an effective immune response to kill cancer cells. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with chronic phase chronic myelogenous leukemia.
Timeline
- Start
- 2005-10
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BCR-ABL junction-specific peptide vaccine | Vaccine | — | Subcutaneous |
| Background | incomplete Freund's adjuvant | Other / unclassified | — | — |